Agenda

Return

C. 53

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	October 4, 2022

Contra

Costa

County

Subject:

Amendment to Purchase Order with Abbott Laboratories Inc. (PO #20985)

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 10/04/2022

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:

Stephanie Trammell, 925-370-5775

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: October 4, 2022
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent or designee to execute, on behalf of the Health Services Director, (1) an amendment to Purchase Order #20985 with Abbott Laboratories, Inc., to increase the payment limit by $900,000 to a new payment limit of $1,700,000 and (2) extend the term of October 1, 2020 through September 30, 2022 to October 1, 2020 through December 31, 2024 to purchase testing reagents and kits for Hepatitis A, Hepatitis B, Hepatitis C, and COVID-19 antibody screening for the Contra Costa Regional Medical Center Public Health Laboratory.

FISCAL IMPACT:

Approval of this action will result in expenditures of up to $1,700,000 over the four-year period and will be funded 100% by Hospital Enterprise Fund I revenues.

BACKGROUND:

Contra Costa County Public Health Laboratory currently provides hepatitis antibody testing for all Contra Costa Health Services (CCHS) clinic patients for routine care, including Contra Costa Regional Medical Center.

BACKGROUND: (CONT'D)

On November 17, 2020, the Board of Supervisors approved agenda item C.41 to execute a purchase order (#20985) with Abbott Labs, Inc., in the amount of $800,000 for the period from October 1, 2020 through September 30, 2022 to purchase hepatitis testing kits and reagents.

During the pandemic, there was a decrease in demand for hepatitis antibody testing that affected the reagent order frequency. As a result of returning demand and to allow for additional programs to be added to the testing menu, an amendment to the existing purchase order is necessary. This purchase order amendment would add funds to accommodate increasing demands and additional volume for program needs and extend the length of time the Contra Costa County Public Health Laboratory can purchase hepatitis antibody screening test kits for the Abbott Architect instrument. Abbott Labs, Inc. is the sole provider of the full menu of readily available reagents for the Abbott Architect instrument. The laboratory has used the Architect instrument, as well as an earlier version since 2012.

CONSEQUENCE OF NEGATIVE ACTION:

If this action is not approved, the Contra Costa Public Health Laboratory would not be able to purchase hepatitis antibody screening kits for patient care. Additionally, invoices would not be paid in a timely manner.

CLERK'S ADDENDUM

Speaker: No name given.